Vericel (VCEL) Revenue (2016 - 2025)
Historic Revenue for Vericel (VCEL) over the last 16 years, with Q3 2025 value amounting to $67.5 million.
- Vericel's Revenue rose 1657.54% to $67.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $258.7 million, marking a year-over-year increase of 1405.06%. This contributed to the annual value of $237.2 million for FY2024, which is 2010.37% up from last year.
- Per Vericel's latest filing, its Revenue stood at $67.5 million for Q3 2025, which was up 1657.54% from $63.2 million recorded in Q2 2025.
- Vericel's Revenue's 5-year high stood at $75.4 million during Q4 2024, with a 5-year trough of $34.5 million in Q3 2021.
- For the 5-year period, Vericel's Revenue averaged around $49.4 million, with its median value being $47.6 million (2021).
- As far as peak fluctuations go, Vericel's Revenue surged by 9745.68% in 2021, and later tumbled by 625.77% in 2022.
- Vericel's Revenue (Quarter) stood at $47.6 million in 2021, then rose by 10.72% to $52.7 million in 2022, then increased by 23.35% to $65.0 million in 2023, then increased by 15.97% to $75.4 million in 2024, then fell by 10.44% to $67.5 million in 2025.
- Its Revenue stands at $67.5 million for Q3 2025, versus $63.2 million for Q2 2025 and $52.6 million for Q1 2025.